51 – 60 of 181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
The cartilage-specific collagen IX and its role in modulation of the complement activity
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2854-2854(
- Contribution to journal › Published meeting abstract
-
Mark
Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix.
(
- Contribution to journal › Article
-
Mark
Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
(
- Contribution to journal › Article
-
Mark
Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.
(
- Contribution to journal › Article
-
Mark
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappa B inhibitor that impairs osteoclastogenesis
(
- Contribution to journal › Article
-
Mark
Proteoglycans and more--from molecules to biology.
(
- Contribution to journal › Scientific review
- 2008
-
Mark
COMP a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
(
- Contribution to journal › Article
-
Mark
The matrix proline/arginine-rich end leucine-rich repeat protein (PRELP) inhibits osteoclastogenesis inactivating NF-kappaB signal (Abstracts of the 35th European Symposium on Calcified Tissues)
2008) 35th European Symposium on Calcified Tissues In Calcified Tissue International 82(Suppl. 1). p.33-33(
- Contribution to journal › Published meeting abstract
-
Mark
The role of histidine rich glycoprotein in the modulation of immune function
(
- Contribution to journal › Published meeting abstract
-
Mark
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity
(
- Contribution to journal › Published meeting abstract